Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Mingshan, Cheng"'
Autor:
Noah E. Berlow, Catherine S. Grasso, Michael J. Quist, Mingshan Cheng, Regina Gandour-Edwards, Brian S. Hernandez, Joel E. Michalek, Christopher Ryan, Paul Spellman, Ranadip Pal, Lynn S. Million, Mark Renneker, Charles Keller
Publikováno v:
Sarcoma, Vol 2020 (2020)
Nonrhabdomyosarcoma soft-tissue sarcomas (STSs) are a class of 50+ cancers arising in muscle and soft tissues of children, adolescents, and adults. Rarity of each subtype often precludes subtype-specific preclinical research, leaving many STS patient
Externí odkaz:
https://doaj.org/article/d09faa8800544e039ad7a8a37d4fa81c
Autor:
Xing Yi Woo, Anuj Srivastava, Philip C. Mack, Joel H. Graber, Brian J. Sanderson, Michael W. Lloyd, Mandy Chen, Sergii Domanskyi, Regina Gandour-Edwards, Rebekah A. Tsai, James Keck, Mingshan Cheng, Margaret Bundy, Emily L. Jocoy, Jonathan W. Riess, William Holland, Stephen C. Grubb, James G. Peterson, Grace A. Stafford, Carolyn Paisie, Steven B. Neuhauser, R. Krishna Murthy Karuturi, Joshy George, Allen K. Simons, Margaret Chavaree, Clifford G. Tepper, Neal Goodwin, Susan D. Airhart, Primo N. Lara, Thomas H. Openshaw, Edison T. Liu, David R. Gandara, Carol J. Bult
Publikováno v:
Cancer Res
Cancer research, vol 82, iss 22
Cancer research, vol 82, iss 22
Patient-derived xenograft (PDX) models are an effective preclinical in vivo platform for testing the efficacy of novel drugs and drug combinations for cancer therapeutics. Here we describe a repository of 79 genomically and clinically annotated lung
Autor:
Jiwon Yang, Jing Jiao, Kyle M. Draheim, Guoxiang Yang, Hongyuan Yang, Li‐Chin Yao, Leonard D. Shultz, Dale L. Greiner, Deepa Rajagopal, Sandrine Vessillier, Curtis C. Maier, Sunish Mohanan, Danying Cai, Mingshan Cheng, Michael A. Brehm, James G. Keck
Publikováno v:
The FASEB Journal. 37
Autor:
Scott Kopetz, Garth Powis, Michael J. Overman, Jeffrey Morris, Bradley M. Broom, Mingshan Cheng, Susan Airhart, Feng Tian, Christopher Bristow, Bahar Salimian Rizi, Alexey V. Sorokin, Ji Wu, Shanequa Manuel, Maria P. Morelli, Andreas Varkaris, David G. Menter, Zhi-Qin Jiang, Kanwal Raghav, Anastasia Katsiampoura
Association between surgical specimen size and rate of PDX establishment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1a3561b3894370a65e992a0deea967
https://doi.org/10.1158/1535-7163.22503978.v1
https://doi.org/10.1158/1535-7163.22503978.v1
Autor:
Darren A.E. Cross, Philip C. Mack, David R. Gandara, James G. Keck, Rebekah A. Burich, Daniel P. Vang, Mingshan Cheng, Darren McKerrecher, M. Raymond V. Finlay, Richard A. Ward, Daniel J. O'Neill, Maria Emanuela Cuomo, Ludovic Ménard, Anna D. Staniszewska, Jonathan P. Orme, Jonathan W. Riess, Matthew J. Martin, Nicolas Floc'h
Supplementary figure 1: Generation of H2073 ASV and H2073 SVD. Supplementary figure 2: H2073 parental and Ex20Ins are dependent on EGFR for survival in vitro. Supplementary figure 3: Effect of TKI on the Sytox Proliferation of H2073 wt, H2073-SVD and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f56c0e6f4081d567187d483f6041777
https://doi.org/10.1158/1535-7163.22505797
https://doi.org/10.1158/1535-7163.22505797
Autor:
Scott Kopetz, Garth Powis, Michael J. Overman, Jeffrey Morris, Bradley M. Broom, Mingshan Cheng, Susan Airhart, Feng Tian, Christopher Bristow, Bahar Salimian Rizi, Alexey V. Sorokin, Ji Wu, Shanequa Manuel, Maria P. Morelli, Andreas Varkaris, David G. Menter, Zhi-Qin Jiang, Kanwal Raghav, Anastasia Katsiampoura
Hematoxylin and eosin staining showing conformity of grade between patient sample and respective established xenografts from both primary and metastatic sites.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2bb06082f7ca75c4469315e54779cb
https://doi.org/10.1158/1535-7163.22503981
https://doi.org/10.1158/1535-7163.22503981
Autor:
Darren A.E. Cross, Philip C. Mack, David R. Gandara, James G. Keck, Rebekah A. Burich, Daniel P. Vang, Mingshan Cheng, Darren McKerrecher, M. Raymond V. Finlay, Richard A. Ward, Daniel J. O'Neill, Maria Emanuela Cuomo, Ludovic Ménard, Anna D. Staniszewska, Jonathan P. Orme, Jonathan W. Riess, Matthew J. Martin, Nicolas Floc'h
EGFR exon 20 insertions (Ex20Ins) account for 4% to 10% of EGFR activating mutations in non–small cell lung cancer (NSCLC). EGFR Ex20Ins tumors are generally unresponsive to first- and second-generation EGFR inhibitors, and current standard of care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de56d8339b2fdb08f9c7f6a79f45f94b
https://doi.org/10.1158/1535-7163.c.6538186.v1
https://doi.org/10.1158/1535-7163.c.6538186.v1
Autor:
Scott Kopetz, Garth Powis, Michael J. Overman, Jeffrey Morris, Bradley M. Broom, Mingshan Cheng, Susan Airhart, Feng Tian, Christopher Bristow, Bahar Salimian Rizi, Alexey V. Sorokin, Ji Wu, Shanequa Manuel, Maria P. Morelli, Andreas Varkaris, David G. Menter, Zhi-Qin Jiang, Kanwal Raghav, Anastasia Katsiampoura
Developing realistic preclinical models using clinical samples that mirror complex tumor biology and behavior are vital to advancing cancer research. While cell line cultures have been helpful in generating preclinical data, the genetic divergence be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fbba52453d564e5c7b8979fa5a18c1e
https://doi.org/10.1158/1535-7163.c.6537579.v1
https://doi.org/10.1158/1535-7163.c.6537579.v1
Autor:
Carol J. Bult, David R. Gandara, Edison T. Liu, Thomas H. Openshaw, Primo N. Lara, Susan D. Airhart, Neal Goodwin, Clifford G. Tepper, Margaret Chavaree, Allen K. Simons, Joshy George, R. Krishna Murthy Karuturi, Steven B. Neuhauser, Carolyn Paisie, Grace A. Stafford, James G. Peterson, Stephen C. Grubb, William Holland, Jonathan W. Riess, Emily L. Jocoy, Margaret Bundy, Mingshan Cheng, James Keck, Rebekah A. Tsai, Regina Gandour-Edwards, Sergii Domanskyi, Mandy Chen, Michael W. Lloyd, Brian J. Sanderson, Joel H. Graber, Philip C. Mack, Anuj Srivastava, Xing Yi Woo
Patient-derived xenograft (PDX) models are an effective preclinical in vivo platform for testing the efficacy of novel drugs and drug combinations for cancer therapeutics. Here we describe a repository of 79 genomically and clinically annotated lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5cefc3df68748c1456699cbfa512e4c
https://doi.org/10.1158/0008-5472.c.6514248.v1
https://doi.org/10.1158/0008-5472.c.6514248.v1
Autor:
Carol J. Bult, David R. Gandara, Edison T. Liu, Thomas H. Openshaw, Primo N. Lara, Susan D. Airhart, Neal Goodwin, Clifford G. Tepper, Margaret Chavaree, Allen K. Simons, Joshy George, R. Krishna Murthy Karuturi, Steven B. Neuhauser, Carolyn Paisie, Grace A. Stafford, James G. Peterson, Stephen C. Grubb, William Holland, Jonathan W. Riess, Emily L. Jocoy, Margaret Bundy, Mingshan Cheng, James Keck, Rebekah A. Tsai, Regina Gandour-Edwards, Sergii Domanskyi, Mandy Chen, Michael W. Lloyd, Brian J. Sanderson, Joel H. Graber, Philip C. Mack, Anuj Srivastava, Xing Yi Woo
Supplementary Table from A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b1a58d4d6ddc9eaba431d6c2bee5b6
https://doi.org/10.1158/0008-5472.22432782
https://doi.org/10.1158/0008-5472.22432782